Visudyne
Visudyne is a medicine authorised by Swissmedic under authorisation number 55269. The authorisation holder is Cheplapharm Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 15 December 1999 and the authorisation is valid without a time limit. ATC code S01LA01 places the medicine in the group Ophthalmologicals.
| Authorisation number | 55269 |
|---|---|
| Name | Visudyne |
| Full name | Visudyne, Pulver zur Herstellung einer Infusionslösung |
| Authorisation holder | Cheplapharm Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | S01LA01 |
| First authorisation | 15 December 1999 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Visudyne, Pulver zur Herstellung einer Infusionslösung | A | 15 December 1999 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 1 | Ampulle(n) | S01LA01 | 11.99.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Visudyne authorised in Switzerland?
Yes. Visudyne is authorised by Swissmedic under authorisation number 55269, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Visudyne have?
Visudyne is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Visudyne?
The authorisation holder is Cheplapharm Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.